[PI-RADS 2.0 for Prostate MRI].

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol (2015) 3.18

The contemporary concept of significant versus insignificant prostate cancer. Eur Urol (2011) 2.29

Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology (2014) 1.78

Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. Eur Urol (2014) 1.76

Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Eur Urol (2015) 1.52

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol (2015) 1.42

Assessment of PI-RADS v2 for the Detection of Prostate Cancer. Eur J Radiol (2016) 1.07

Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol (2015) 1.02

Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen. J Urol (2014) 0.88

Multicentre evaluation of target and systematic biopsies using Magnetic Resonance and Ultrasound Image-Fusion guided Transperineal Prostate Biopsy in patients with a previous negative biopsy. BJU Int (2016) 0.84

Seminal vesicle invasion: accuracy and analysis of infiltration patterns with high-spatial resolution T2-weighted sequences on endorectal magnetic resonance imaging. Urol Int (2013) 0.83

MRI of the Prostate: Recommendations on Patient Preparation and Scanning Protocol. Rofo (2016) 0.81

Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice. Clin Genitourin Cancer (2016) 0.81

Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion. Int J Radiat Oncol Biol Phys (2016) 0.80

Prostate cancer: Can imaging accurately diagnose lymph node involvement? Nat Rev Urol (2015) 0.80

Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol. PeerJ (2016) 0.78

Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection. Radiology (2016) 0.78

Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease. Prostate (2016) 0.78

Magnetic Resonance Imaging for Membranous Urethral Length Assessment Prior to Radical Prostatectomy: Can it Really Improve Prostate Cancer Management? Eur Urol (2016) 0.78

Evaluation of extracapsular extension in prostate cancer using qualitative and quantitative multiparametric MRI. J Magn Reson Imaging (2016) 0.77